Questions in Mild Asthma: An Official American Thoracic Society Research Statement
暂无分享,去创建一个
B. Yawn | C. Jenkins | E. Israel | L. Boulet | P. O'Byrne | A. Yorgancioglu | W. Moore | L. Bacharier | G. Gauvreau | S. Lazarus | M. Kraft | N. Hanania | R. Pleasants | R. Beasley | A. Papi | E. Schneider-Futschik | T. Guilbert | H. Reddel | K. Sumino | A. Papi | N. Lugogo | P. Akuthota | F. Martinez | A. Mohan | David Price | Paul M O'Byrne | Paul M. O'Byrne
[1] Trung Nghia Tran,et al. Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study , 2022, Thorax.
[2] C. Janson,et al. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study. , 2022, Respiratory medicine.
[3] M. Idzko,et al. European Respiratory Society guidelines for the diagnosis of asthma in adults , 2022, European Respiratory Journal.
[4] C. Ambrose,et al. Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study , 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.
[5] I. Pavord,et al. Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study , 2022, BMJ Open.
[6] F. Albers,et al. Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study. , 2021, Annals of Allergy, Asthma & Immunology.
[7] G. Brusselle,et al. The ALPACA study: (In)Appropriate LAMA Prescribing in Asthma: a Cohort Analysis. , 2021, Pulmonary pharmacology & therapeutics.
[8] N. Hanania,et al. Revisiting Mild Asthma: Current Knowledge and Future Needs. , 2021, Chest.
[9] I. Pavord,et al. Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide , 2021, Thorax.
[10] R. Murray,et al. Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities. , 2021, The journal of allergy and clinical immunology. In practice.
[11] E. Serlachius,et al. Targeting excessive avoidance behavior to reduce anxiety related to asthma: A feasibility study of an exposure-based treatment delivered online , 2021, Internet interventions.
[12] M. Puu,et al. Efficacy and safety of as-needed budesonide-formoterol in adolescents with mild asthma. , 2021, The journal of allergy and clinical immunology. In practice.
[13] Todor A Popov,et al. Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. , 2021, Chest.
[14] I. Pavord,et al. Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort , 2021, European Respiratory Journal.
[15] C. Janson,et al. Risk of re-hospitalization and death in patients hospitalized due to asthma. , 2020, The journal of allergy and clinical immunology. In practice.
[16] D. Price,et al. Potential severe asthma hidden in UK primary care. , 2020, The journal of allergy and clinical immunology. In practice.
[17] Colin G. Walsh,et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group , 2020, The Journal of allergy and clinical immunology.
[18] D. Roach,et al. 129Xe MRI as a measure of clinical disease severity for pediatric asthma. , 2020, The Journal of allergy and clinical immunology.
[19] A. Leow,et al. Impact of interventions targeting anxiety and depression in adults with asthma , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.
[20] I. Pavord,et al. Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma , 2020, European Respiratory Journal.
[21] I. Pavord,et al. The burden of exacerbations in mild asthma: a systematic review , 2020, ERJ Open Research.
[22] J. Malka-Rais,et al. FeNO Response to Oral Corticosteroids in Children with Mild to Moderate Asthma: Influence of Race. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] Y. Hellsten,et al. Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis , 2020, European Respiratory Journal.
[24] Yuewei Liu,et al. Recent trends in current asthma prevalence among US adults, 2009-2018. , 2020, The journal of allergy and clinical immunology. In practice.
[25] N. Barnard,et al. The role of nutrition in asthma prevention and treatment , 2020, Nutrition reviews.
[26] M. Cabana,et al. Heterogeneity of mild-to-moderate persistent asthma in children: Confirmation by latent class analysis and association with one-year outcomes. , 2020, The journal of allergy and clinical immunology. In practice.
[27] Kathryn J. Sullivan,et al. Structural and Social Determinants of Health in Asthma in Developed Economies: a Scoping Review of Literature Published Between 2014 and 2019 , 2020, Current Allergy and Asthma Reports.
[28] C. Janson,et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme , 2020, European Respiratory Journal.
[29] D. Price,et al. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey , 2019, BMJ Open.
[30] A. Sheikh,et al. GINA 2019: a fundamental change in asthma management , 2019, European Respiratory Journal.
[31] M. Fletcher,et al. A review of the burden and management of mild asthma in adults - Implications for clinical practice. , 2019, Respiratory medicine.
[32] M. Schuers,et al. Impact of non-drug therapies on asthma control: A systematic review of the literature , 2019, The European journal of general practice.
[33] L. Lynd,et al. Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression. , 2018, The journal of allergy and clinical immunology. In practice.
[34] Gregory D. Kearney,et al. Insights Into the Environmental Health Burden of Childhood Asthma , 2018, Environmental health insights.
[35] P. O'Byrne,et al. Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge. , 2017, The Journal of allergy and clinical immunology.
[36] A. Ray,et al. Neutrophilic Inflammation in Asthma and Association with Disease Severity. , 2017, Trends in immunology.
[37] L. Wood,et al. Diet and Asthma: Is It Time to Adapt Our Message? , 2017, Nutrients.
[38] E. Israel,et al. Race is associated with differences in airway inflammation in patients with asthma , 2017, The Journal of allergy and clinical immunology.
[39] Todor A Popov,et al. Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative. , 2017, The journal of allergy and clinical immunology. In practice.
[40] E. Burchard,et al. Perceived Discrimination Associated With Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies , 2017, Chest.
[41] M. Dibonaventura,et al. A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys , 2017, The Journal of asthma : official journal of the Association for the Care of Asthma.
[42] M. Cabana,et al. Individualized therapy for persistent asthma in young children. , 2016, The Journal of allergy and clinical immunology.
[43] P. Gergen,et al. Asthma phenotypes in inner-city children. , 2016, The Journal of allergy and clinical immunology.
[44] S. Lam,et al. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study , 2015, Respiratory Research.
[45] Ioannis Pandis,et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.
[46] P. O'Byrne,et al. T Helper 17 Cells and Related Cytokines after Allergen Inhalation Challenge in Allergic Asthmatics , 2014, International Archives of Allergy and Immunology.
[47] N. Rabinovitch,et al. Eczema and race as combined determinants for differential response to step-up asthma therapy. , 2014, The Journal of allergy and clinical immunology.
[48] P. O'Byrne,et al. Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[49] Masatsugu Yamamoto,et al. Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response , 2014, Allergy, Asthma & Clinical Immunology.
[50] P. O'Byrne,et al. Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma. , 2014, The Journal of allergy and clinical immunology.
[51] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[52] K. Carlsen,et al. Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction , 2013, Thorax.
[53] Tonya S. King,et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. , 2012, JAMA.
[54] L. Gerald,et al. Feasibility of exercising adults with asthma: a randomized pilot study , 2012, Allergy, Asthma & Clinical Immunology.
[55] J. Celedón,et al. The Challenge of Asthma in Minority Populations , 2012, Clinical Reviews in Allergy & Immunology.
[56] David M. Shade,et al. Does age impact the obese asthma phenotype? Longitudinal asthma control, airway function, and airflow perception among mild persistent asthmatics. , 2011, Chest.
[57] P. O'Byrne,et al. Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. , 2010, The Journal of allergy and clinical immunology.
[58] L. Boulet,et al. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma. , 2009, Respiratory medicine.
[59] Clive Brown,et al. Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. , 2009, Chest.
[60] I. Pavord,et al. A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.
[61] C. Janson,et al. Asthma mortality among Swedish children and young adults, a 10-year study. , 2008, Respiratory medicine.
[62] E. Chen,et al. Does the social environment contribute to asthma? , 2008, Immunology and allergy clinics of North America.
[63] William W Busse,et al. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. , 2008, The Journal of allergy and clinical immunology.
[64] D. Broide. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. , 2008, The Journal of allergy and clinical immunology.
[65] D. Postma,et al. Severe exacerbations predict excess lung function decline in asthma , 2007, European Respiratory Journal.
[66] C. Delacourt,et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations , 2007, Allergy.
[67] A. Wu,et al. Are Physician Estimates of Asthma Severity Less Accurate in Black than in White Patients? , 2007, Journal of General Internal Medicine.
[68] Sally E Wenzel,et al. Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.
[69] William W Busse,et al. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[70] C. Jenkins,et al. Double blind randomised controlled trial of two different breathing techniques in the management of asthma , 2006, Thorax.
[71] M. Kraus-filarska,et al. [Airway remodeling in asthma]. , 2006, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[72] K. Chapman. Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature. , 2005, Respiratory medicine.
[73] D. Postma,et al. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. , 2005, The Journal of allergy and clinical immunology.
[74] Rosalind Wright,et al. Population disparities in asthma. , 2005, Annual review of public health.
[75] S. Suissa,et al. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma , 2002, Thorax.
[76] P. O'Byrne,et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. , 2002, American journal of respiratory and critical care medicine.
[77] K. J. Macleod,et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.
[78] A Tattersfield,et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.
[79] R. Townley,et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. , 2001, The European respiratory journal.
[80] L. Boulet,et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.
[81] Inman,et al. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low‐dose allergen challenge in atopic asthmatics , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[82] P. O'Byrne,et al. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.
[83] L. Boulet,et al. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. , 1999, The European respiratory journal.
[84] J. Bousquet,et al. Airway inflammation in mild intermittent and in persistent asthma. , 1998, American journal of respiratory and critical care medicine.
[85] A. Wardlaw,et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.